Establishment Labs Holdings Inc.
NASDAQ:ESTAMedical - Devices
+$2.65 today
- Market cap
- $2.11B
- Beta
- 1.11
- P/E (TTM)
- -57.6
- EPS (TTM)
- -$1.48
Volume 0.38M
Average 0.50M
ESTA Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Establishment Labs Holdings Inc.NASDAQ: ESTA
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables turns positive
Q3 FY2026 accounts payables was $3.86M, compared with -$16.32M a year earlier. Trailing-twelve-month accounts payables was -$3.76M.
Context
- Accounts payables amounted to 1.1% of revenue in FY2025, down 2.9 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near $3.86M or moves back toward the trailing-twelve-month quarterly average of -$939.31K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (2.3M) USD
- Year-over-year change
- -134.4%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.3M) | -134.4% |
| FY2024 | 2024-12-31 | 6.67M | -64.8% |
| FY2023 | 2023-12-31 | 18.96M | +333.2% |
| FY2022 | 2022-12-31 | 4.38M | -11.8% |
| FY2021 | 2021-12-31 | 4.96M | — |
Accounts Payables vs competitors
How ESTA compares with its peers on the latest reported figures
- ESTA's LTM Sep 2026 accounts payables of $3.76M is the 2nd largest of the 4 companies compared; the peer median is $2.05M.
- Its year-over-year change of -161.7% is the lowest of 4, against a peer median of +308.6%.
- Accounts payables amounts to 1.4% of revenue for ESTA, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $25.54M | +1844.4% | +15.5% | 1.6% | |
| LTM Sep 2026 | $3.76M | -161.7% | — | 1.4% | |
| LTM Mar 2026 | $2.05M | +11.5% | -17.9% | 0.5% | |
| LTM Jun 2026 | $1.17M | +308.6% | — | 1.5% | |
| Peer median (excluding ESTA) | $2.05M | +308.6% | -1.2% | 1.5% | |
Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (41.14M) | (75.21M) | (78.5M) | (84.6M) | (51.06M) |
| Depreciation & Amortization | 4.12M | 4.34M | 4.88M | 7.58M | 10.47M |
| Deferred Income Tax | 7K | 86K | (3.71M) | (2.18M) | 6.96M |
| Stock-Based Compensation | 10.41M | 13.36M | 14.86M | 15.37M | (11.42M) |
| Change in Working Capital | (6.44M) | (21.54M) | (34.13M) | (15.5M) | (13.17M) |
| Accounts Receivables | (6.7M) | (12.33M) | (11.56M) | (26.28M) | (11.47M) |
| Inventory | (7.64M) | (10.9M) | (42.23M) | (471K) | (7.06M) |
| Accounts Payables | 4.96M | 4.38M | 18.96M | 6.67M | (2.3M) |
| Other Working Capital | 2.94M | (2.69M) | 701K | 4.58M | 7.65M |
| Other Non-Cash Items | 5.51M | 26.8M | 8.08M | 20.81M | 7.33M |
| Operating Cash Flow | (27.53M) | (52.17M) | (88.51M) | (58.52M) | (50.89M) |
| Capital Expenditures | (6.73M) | (34.27M) | (24.55M) | (15.56M) | (6.72M) |
| Acquisitions (Net) | 0 | 0 | 0 | (50K) | (307K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (434K) | (525K) | (16.64M) | (9.45M) | (672K) |
| Investing Cash Flow | (7.16M) | (34.79M) | (24.55M) | (15.61M) | (7.03M) |
| Debt Repayment | (175K) | 96.39M | 0 | 24.47M | 33.48M |
| Common Stock Issued | 4.58M | 3.87M | 84.54M | 99.48M | 7.59M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (356K) | (4K) | 1.69M | 1.94M | (637K) |
| Financing Cash Flow | 4.05M | 100.26M | 86.23M | 125.9M | 40.43M |
| Effect of Forex Changes | (465K) | (358K) | 513K | (1.46M) | 2.71M |
| Net Change in Cash | (31.11M) | 12.94M | (26.32M) | 50.31M | (14.78M) |
| Free Cash Flow | (34.26M) | (86.43M) | (113.06M) | (74.08M) | (57.61M) |
Establishment Labs Holdings Inc.
NASDAQ:ESTA
Intrinsic Alpha fair value
Locked
Current Price
$70.80
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.